How to Cite
Abstract
Cervical cancer is a major public health problem in developing countries, which represents a current challenge due to high mortality, with 90 percent % of deaths from this cause, which occurs in low- to middle-income countries. Cervical cancer comprises 8 percent of all cancers among women and is the fourth most common cancer in women after breast, colon, and lung cancers. Squamous cell carcinoma together with adenocarcinoma constitutes more than 98% of all types of cervical cancer. approximately one third of cancerous tumors are related to inflammation induced by microorganisms, in this case cervical cancer is closely related to the human papillomavirus, especially with types 16 and 18 involved in 99% of this type of cancer. It is important to note that the symptoms of cervical cancer generally occur in late stages of the disease, so prevention with screening methods is essential to diagnose both premalignant and cancerous lesions.
Keywords
References
Osorio-Castaño, J., Pérez-Villa, M., Montoya-Zapata, C., & Cardona-Restrepo, F. (2020). Características citológicas previas al diagnóstico de cáncer de cérvix en mujeres de Medellín (Colombia). Universidad Y Salud, 22(3), 231-237. https://doi.org/10.22267/rus.202203.195
Shu, Pei MDa; Li, Rui BSb; Xie, Dan MMc; He, Ying MDd; Wang, Xin PhDa,∗; Li, Qingli PhDc,∗ Clinical profile and treatment outcome of collision carcinoma in cervix, Medicine: March 2020 - Volume 99 - Issue 11 - p e19131 doi: 10.1097/MD.0000000000019131, https://journals.lww.com/md-journal/Fulltext/2020/03130/Clinical_profile_and_treatment_outcome_of.15.aspx
Xiaofan Lu*, Liyun Jiang*, Liya Zhang*, Yue Zhu*, Wenjun Hu*, Jiashuo Wang*, Xinjia Ruan*, Zhengbao Xu*, Xiaowei Meng*, Jun Gao*, Xiaoping Su† and Fangrong Yan, (2019), Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome, Published by Elsevier Inc, https://doi.org/10.1016/j.neo.2019.04.003
Sarmiento Medina, M. I., & Puerto de Amaya, M. (2020). Factores de riesgo para cáncer de cuello uterino y resultados de prueba de Papanicolaou en adolescentes marginadas de Bogotá, Colombia. Revista Ciencias De La Salud, 18(1),37-51. https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.8746
Carrero, Yenddy N, Callejas, Diana E, Mosquera, Jesús A, (2021), In situ immunopathological events in human cervical intraepithelial neoplasia and cervical cancer: Review, Published by Elsevier Inc, https://doi.org/10.1016/J.TRANON.2021.101058
Sarah Feldman, MD, MPH, Annekathryn Goodman, MD, MPH, MS, Jeffrey F Peipert, MD, PhD, (2021), Screening for cervical cancer in resource-rich settings, UpToDate, https://login.binasss.idm.oclc.org/login?qurl=https://www.uptodate.com%2f
Alfaro Cartín S, Hernández Steller H, Jiménez Jiménez G, Lami Casaus L, (2021), Consenso del tratamiento farmacológico del cáncer, https://acomedcr.com/consenso-farmacologico-del-cancer/
Laberiano Fernández CD. Estado del tamizaje del cáncer de cérvix en países de América Latina desde la perspectiva de los profesionales de salud. Rev Peru Ginecol Obstet. 2020;66(1):37-40. DOI: https://doi.org/10.31403/rpgo.v66i2231
Lynette Denny, (2021), Screening for cervical cancer in resource-limited settings, UpToDate, https://login.binasss.idm.oclc.org/login?qurl=https://www.uptodate.com%2f
Osorio-Castaño, J., Pérez-Villa, M., Montoya-Zapata, C., & Cardona-Restrepo, F. (2020). Características citológicas previas al diagnóstico de cáncer de cérvix en mujeres de Medellín (Colombia). Universidad Y Salud, 22(3), 231-237. https://doi.org/10.22267/rus.202203.195
De Vita V Hellman S, Rosenberg S, (2019), Cancer: Principles and Practice of Oncology. Lippincont 11th edition, Wolters Kluwer.
Amer Karam, (2021), Cáncer de cuello uterino en el embarazo, UpToDate, Inc, https://login.binasss.idm.oclc.org/login?qurl=https://www.uptodate.com%2fcontents%2fcervical-cancer-in-pregnancy%2fprint%3fsearch%3dcancer
Leaño Berrios J, Orieth Mena Revollo L, (2020), Correlación citológica, colposcópica e histológica de lesiones precancerígenas en cérvix, Rev Med La Paz, https://login.binasss.idm.oclc.org/login?qurl
Sarah Feldman, MPH, Annekathryn Goodman, MPH, MS, Jeffrey F Peipert, (2021), Screening for cervical cancer in resource-rich settings, https://login.binasss.idm.oclc.org/login?qurl=https://www.uptodate.com%2f
Sarah Feldman, Christopher P Crum,(2021), Cervical cancer screening tests: Techniques for cervical cytology and human papillomavirus testing, UpToDate, https://login.binasss.idm.oclc.org/login?qurl=https://www.uptodate.com%2f
Lynette Denny, (2021), Cervical cancer screening tests: Visual inspection methods, UpToDate, https://login.binasss.idm.oclc.org/login?qurl=https://www.uptodate.com%2f
A. Arbeláez-Vásquez, et al. Implementación de la nueva guía práctica clínica para la detección y manejo de lesiones precancerosas de cuello uterino en mujeres de la ciudad de Cali, Colombia. Infectio 2020; 24(1):20-26, https://login.binasss.idm.oclc.org/login?qurl
Marañón Cardonne T, Mastrapa Cantillo K, Flores Barroso Y, Vaillant Lora L, Landazuri Llago S, (2017), Prevención y control del cáncer de cuello uterino, Correo científico médico de Holguín
Jiayao Lei, Ph.D., Alexander Ploner, Ph.D., K. Miriam Elfström, Ph.D., Jiangrong Wang, Ph.D., Adam Roth, M.D., Ph.D., Fang Fang, M.D., Ph.D., Karin Sundström, M.D., Ph.D., Joakim Dillner, M.D., Ph.D., and Pär Sparén, (2020), HPV Vaccination and the Risk of Invasive Cervical Cancer, The New England Journal of Medicine, https://www.nejm.org/doi/full/10.1056/NEJMoa1917338
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2022 Array